TY  - GEN
AU  - Kafatos, G
AU  - Andrews, N
AU  - McConway, K J
AU  - Anastassopoulou, C
AU  - Barbara, C
AU  - De Ory, Fernando de
AU  - Johansen, K
AU  - Mossong, J
AU  - Prosenc, K
AU  - Vranckx, R
AU  - Nardone, A
AU  - Pebody, Richard
AU  - Farrington, P
PY  - 2015
DO  - 10.1017/S095026881400301X
UR  - http://hdl.handle.net/20.500.12105/11473
AB  - The aim of the European Sero-Epidemiology Network 2 (ESEN2) project was to estimate age-specific seroprevalence for a number of vaccine-preventable diseases in Europe. To achieve this serosurveys were collected by 22 national laboratories. To adjust...
LA  - eng
PB  - Cambridge University Press
KW  - ESEN2
KW  - Seroprevalence
KW  - Serosurvey
KW  - Standardization
KW  - Vaccination
KW  - Adolescent
KW  - Adult
KW  - Chickenpox
KW  - Child
KW  - Child, Preschool
KW  - Diphtheria
KW  - Diphtheria Toxoid
KW  - Europe
KW  - Hepatitis A
KW  - Humans
KW  - Infant
KW  - Measles
KW  - Mumps
KW  - Reference Standards
KW  - Rubella
KW  - Seroepidemiologic Studies
KW  - Viral Vaccines
KW  - Young Adult
TI  - Estimating seroprevalence of vaccine-preventable infections: is it worth standardizing the serological outcomes to adjust for different assays and laboratories?
TY  - research article
ER  -